Bristol Myers Squibb (BMY)

Financing Cash Flow

-$11.71B

TTM · Period ending: · USD

BMY logo

BMY Financing Cash Flow

Latest reported-$11.71B
BMY TTM Cash from Financing (-$1.49B → -$11.71B)
High-resolution chart · PNG

BMY financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bristol Myers Squibb Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
-11,709,000,000
-10,915,000,000
-10,348,000,000
-5,961,000,000
-8,323,000,000
-10,510,000,000
5,127,000,000
7,736,000,000
6,428,000,000
8,278,000,000
-9,416,000,000
-13,629,000,000
-13,012,000,000
-14,359,000,000
-16,962,000,000
-17,683,000,000
-14,920,000,000
-14,582,000,000
-16,224,000,000
-8,774,000,000
-9,581,000,000
-7,392,000,000
-1,151,000,000
-12,311,000,000
-10,665,000,000
8,596,000,000
7,621,000,000
14,720,000,000
14,941,000,000
-4,342,000,000
-3,535,000,000
-4,309,000,000
-4,295,000,000
-4,286,000,000
-4,077,000,000
-3,315,000,000
-3,155,000,000
-2,701,000,000
-2,638,000,000
-3,134,000,000
-3,288,000,000
-3,619,000,000
-3,351,000,000
-2,496,000,000
-2,324,000,000
-1,927,000,000
-2,437,000,000
-1,495,000,000
-1,587,000,000
-2,216,000,000
-1,068,000,000
-2,737,000,000
-3,806,000,000
-3,541,000,000
-4,333,000,000
-4,129,000,000
-3,144,000,000
-2,801,000,000
-2,657,000,000
-3,567,000,000
-3,561,000,000
-3,549,000,000
-3,343,000,000
-685,000,000
-643,000,000
-858,000,000
-17,000,000
-1,614,000,000
-3,172,000,000
-1,493,000,000
-2,582,000,000
-2,503,000,000
-2,133,000,000
-3,366,000,000
-3,213,000,000
-4,464,000,000
-3,224,000,000
-3,547,000,000
-3,351,000,000
349,000,000
438,000,000
-1,976,000,000
-3,665,000,000
-5,996,000,000
-5,371,000,000
-2,697,000,000
-503,000,000
-611,000,000
-813,000,000
-1,377,000,000
-1,052,000,000
-498,000,000
-1,008,000,000
-234,000,000
-1,117,000,000
-3,494,000,000
3,424,000,000
2,454,000,000
1,768,000,000
3,059,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.